Table 2 PCR uncorrected treatment responses for artemether-lumefantrine or dihydroartemisinin-piperaquine by day 28 and 42 days

Kouvé site (Day 28)

 AL^e (n = 97)

8 (8.2)

0

0.0 (0.0–4.1)

4

4.5 (1.2–11.1)

6

6.7 (2.5–14.1)

79

88.8 (80.3–94.5)

88.9 (80.4–93.9)

 DP^f (n = 95)

5 (5.3)

0

0.0 (0.0–4.0)

0

0.0 (0.0–4.0)

1

1.1 (0.0–6.0)

89

98.9 (94.0–100)

98.9 (92.7–99.8)

Anié site (Day 28)

 AL^e (n = 82)

3 (3.7)

0

0.0 (0.0–4.6

4

5.1 (1.4–12.5

5

6.3 (2.1–14.2)

70

88.6 (79.5–94.7)

88.6 (79.3–93.9)

 DP^f (n = 83)

7 (8.4)

0

0.0 (0.0–4.7)

1

1.3 (0–7.1)

1

1.3 (0–7.1)

74

97.4 (90.8–99.7

97.4 (89.9–99.3)

Kouvé site (Day 42)

 AL^e (n = 97)

8 (8.2)

0

0.0 (0.0–4.1)

6

6.7 (2.5–14.1)

10

11.2 (5.5–19.7)

73

82.0 (72.5–89.4)

82.2 (72.6–88.7)

 DP^f (n = 95)

6 (6.3)

0

0.0 (0.0–4.1)

2

2.2 (0.3–7.9)

5

5.6 (1.8–12.6)

82

92.1 (84.5–96.8)

92.3 (84.5–96.2)

Anié site (Day 42)

 AL^e (n = 82)

3 (3.7)

0

0.0 (0.0–4.6)

5

6.3 (2.1–14.2)

8

10.1 (4.5–19.0)

66

83.5 (73.5–90.9)

83.5 (73.4–90.1)

 DP^f (n = 83)

7 (8.4)

0

0.0 (0.0–4.7)

1

1.3 (0.0–7.1)

3

3.9 (0.8–11.1)

72

94.7 (87.1–98.5)

94.7 (86.6–98.0)